Atherectomy Plus Balloon Angioplasty in Treating Femoropopliteal Arterial Disease in Comparison to Balloon Angioplasty Alone: A Systematic Review and Meta-analysis

[1]  Xin Wang,et al.  Atherectomy Combined with Balloon Angioplasty versus Balloon Angioplasty Alone for de Novo Femoropopliteal Arterial Diseases: A Systematic Review and Meta-analysis of Randomised Controlled Trials. , 2021, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[2]  R. Yeh,et al.  Longitudinal Assessment of Safety of Femoropopliteal Endovascular Treatment With Paclitaxel-Coated Devices Among Medicare Beneficiaries: The SAFE-PAD Study. , 2021, JAMA internal medicine.

[3]  M. Uğurlucan,et al.  Efficacy of Rotational Atherectomy followed by Drug-Coated Balloon Angioplasty for the treatment of Femoropopliteal Lesions - Comparison with sole Drug-Coated Balloon Revascularization: Two-year outcomes. , 2020, Annals of vascular surgery.

[4]  P. Danielsson,et al.  Mortality with Paclitaxel-Coated Devices in Peripheral Artery Disease. , 2020, The New England journal of medicine.

[5]  A. Schwertner,et al.  Atherectomy with balloon angioplasty compared to balloon angioplasty alone for the treatment of chronic limb threatening ischemia: A national surgical quality improvement program database analysis , 2020, Vascular.

[6]  J. Ioannidis,et al.  Mortality and Paclitaxel-Coated Devices , 2020, Circulation.

[7]  D. Kokkinidis,et al.  Two-Year Outcomes of Orbital Atherectomy Combined With Drug-Coated Balloon Angioplasty for Treatment of Heavily Calcified Femoropopliteal Lesions , 2020, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

[8]  Yongquan Gu,et al.  Midterm Outcome of Directional Atherectomy Combined with Drug-Coated Balloon Angioplasty versus Drug-Coated Balloon Angioplasty Alone for Femoropopliteal Arteriosclerosis Obliterans. , 2020, Annals of vascular surgery.

[9]  Z. Chang,et al.  Directional Atherectomy with Antirestenotic Therapy for Femoropopliteal Artery Disease: A Systematic Review and Meta-Analysis. , 2019, Journal of vascular and interventional radiology : JVIR.

[10]  S. Spiliopoulos,et al.  Risk of Death Following Application of Paclitaxel‐Coated Balloons and Stents in the Femoropopliteal Artery of the Leg: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials , 2018, Journal of the American Heart Association.

[11]  T. Bisdas,et al.  Directional Atherectomy With Antirestenotic Therapy vs Drug-Coated Balloon Angioplasty Alone for Common Femoral Artery Atherosclerotic Disease , 2018, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

[12]  W. Gray,et al.  Jetstream Atherectomy System treatment of femoropopliteal arteries: Results of the post-market JET Registry. , 2017, Cardiovascular revascularization medicine : including molecular interventions.

[13]  A. Tzafriri,et al.  Calcified plaque modification alters local drug delivery in the treatment of peripheral atherosclerosis , 2017, Journal of controlled release : official journal of the Controlled Release Society.

[14]  D. Scheinert,et al.  Directional Atherectomy Followed by a Paclitaxel-Coated Balloon to Inhibit Restenosis and Maintain Vessel Patency , 2017, Circulation. Cardiovascular interventions.

[15]  T. Bisdas,et al.  Directional Atherectomy With Antirestenotic Therapy vs Drug-Coated Balloon Angioplasty Alone for Isolated Popliteal Artery Lesions , 2017, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

[16]  D. Kokkinidis,et al.  Mid‐term outcomes of orbital atherectomy combined with drug‐coated balloon angioplasty for treatment of femoropopliteal disease , 2017, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[17]  Sundeep Mishra,et al.  Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease , 2017, Current Cardiology Reports.

[18]  M. Shishehbor,et al.  Nationwide Trends of Hospital Admission and Outcomes Among Critical Limb Ischemia Patients: From 2003-2011. , 2016, Journal of the American College of Cardiology.

[19]  S. Himmelstein,et al.  The COMPLIANCE 360° Trial: a randomized, prospective, multicenter, pilot study comparing acute and long-term results of orbital atherectomy to balloon angioplasty for calcified femoropopliteal disease. , 2014, The Journal of invasive cardiology.

[20]  P. Krishnan,et al.  Effective Endovascular Treatment of Calcified Femoropopliteal Disease With Directional Atherectomy and Distal Embolic Protection: Final Results of the DEFINITIVE Ca++ Trial , 2014, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[21]  S. Spiliopoulos,et al.  Emerging Stent and Balloon Technologies in the Femoropopliteal Arteries , 2014, TheScientificWorldJournal.

[22]  N. Shammas,et al.  Comparison of Orbital Atherectomy Plus Balloon Angioplasty vs. Balloon Angioplasty Alone in Patients With Critical Limb Ischemia: Results of the CALCIUM 360 Randomized Pilot Trial , 2012, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

[23]  E. Stabile,et al.  Combined treatment of heavy calcified femoro-popliteal lesions using directional atherectomy and a paclitaxel coated balloon: One-year single centre clinical results. , 2012, Cardiovascular revascularization medicine : including molecular interventions.

[24]  N. Shammas,et al.  Percutaneous lower-extremity arterial interventions with primary balloon angioplasty versus Silverhawk atherectomy and adjunctive balloon angioplasty: randomized trial. , 2011, Journal of vascular and interventional radiology : JVIR.

[25]  R. Langer,et al.  Ethnic-specific prevalence of peripheral arterial disease in the United States. , 2007, American journal of preventive medicine.

[26]  M. Criqui,et al.  Peripheral Arterial Disease Detection, Awareness, and Treatment in Primary Care , 2001 .

[27]  S. Arain,et al.  A critical view of the peripheral atherectomy data in the treatment of infrainguinal arterial disease. , 2014, The Journal of invasive cardiology.

[28]  John V. White,et al.  2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2011, Journal of the American College of Cardiology.